336 related articles for article (PubMed ID: 11327115)
1. Telomerase activation, cellular immortalization and cancer.
Hahn WC; Meyerson M
Ann Med; 2001 Mar; 33(2):123-9. PubMed ID: 11327115
[TBL] [Abstract][Full Text] [Related]
2. Prospects for anti-neoplastic therapies based on telomere biology.
Stewart SA; Hahn WC
Curr Cancer Drug Targets; 2002 Mar; 2(1):1-17. PubMed ID: 12188917
[TBL] [Abstract][Full Text] [Related]
3. Telomeres, telomerase, and myc. An update.
Cerni C
Mutat Res; 2000 Jan; 462(1):31-47. PubMed ID: 10648922
[TBL] [Abstract][Full Text] [Related]
4. Haploinsufficiency of hTERT leads to telomere dysfunction and radiosensitivity in human cancer cells.
Hauguel T; Bunz F
Cancer Biol Ther; 2003; 2(6):679-84. PubMed ID: 14688476
[TBL] [Abstract][Full Text] [Related]
5. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres.
Guilleret I; Benhattar J
Exp Cell Res; 2003 Oct; 289(2):326-34. PubMed ID: 14499633
[TBL] [Abstract][Full Text] [Related]
6. The significance of telomerase activation and cellular immortalization in human cancer.
Newbold RF
Mutagenesis; 2002 Nov; 17(6):539-50. PubMed ID: 12435851
[TBL] [Abstract][Full Text] [Related]
7. The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).
Engelhardt M; Martens UM
Oncol Rep; 1998; 5(5):1043-52. PubMed ID: 9683806
[TBL] [Abstract][Full Text] [Related]
8. Telomere length maintenance in aging and carcinogenesis.
Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F
Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502
[TBL] [Abstract][Full Text] [Related]
9. Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.
Roake CM; Artandi SE
Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28289249
[TBL] [Abstract][Full Text] [Related]
10. Telomeres and telomerase in human health and disease.
Tzukerman M; Selig S; Skorecki K
J Pediatr Endocrinol Metab; 2002 Mar; 15(3):229-40. PubMed ID: 11924925
[TBL] [Abstract][Full Text] [Related]
11. [Physiopathologic implications of telomerase].
Santos Ruiz A; Cascales Angosto M
An R Acad Nac Med (Madr); 2000; 117(2):427-44; discussion 444-7. PubMed ID: 11209552
[TBL] [Abstract][Full Text] [Related]
12. Telomeres and telomerase: implications for cancer and aging.
Shay JW; Wright WE
Radiat Res; 2001 Jan; 155(1 Pt 2):188-193. PubMed ID: 11121233
[TBL] [Abstract][Full Text] [Related]
13. Telomere and telomerase in stem cells: relevance in ageing and disease.
Choudhary B; Karande AA; Raghavan SC
Front Biosci (Schol Ed); 2012 Jan; 4(1):16-30. PubMed ID: 22202040
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in cancer as a diagnostic and therapeutic target.
Kyo S; Takakura M; Inoue M
Histol Histopathol; 2000 Jul; 15(3):813-24. PubMed ID: 10963125
[TBL] [Abstract][Full Text] [Related]
15. Telomeres and telomerases: intimations of immortality.
Crocker J
Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):889-90. PubMed ID: 11507350
[TBL] [Abstract][Full Text] [Related]
16. [Telomeres, telomerase and development of cancer].
Andersen TI
Tidsskr Nor Laegeforen; 1998 May; 118(13):2043-6. PubMed ID: 9656791
[TBL] [Abstract][Full Text] [Related]
17. Senescence and immortalization: role of telomeres and telomerase.
Shay JW; Wright WE
Carcinogenesis; 2005 May; 26(5):867-74. PubMed ID: 15471900
[TBL] [Abstract][Full Text] [Related]
18. [The role of telomere-binding proteins in carcinogenesis].
Aragona M; Pontoriero A; Panetta S; La Torre I; La Torre F
Minerva Med; 2000; 91(11-12):299-304. PubMed ID: 11253711
[TBL] [Abstract][Full Text] [Related]
19. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
[TBL] [Abstract][Full Text] [Related]
20. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity.
Yi X; White DM; Aisner DL; Baur JA; Wright WE; Shay JW
Neoplasia; 2000; 2(5):433-40. PubMed ID: 11191110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
